Catawba Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $1.12M | Buy |
11,760
+140
| +1% | +$13.3K | 0.26% | 85 |
|
|
2018
Q1 | $1.02M | Sell |
11,620
-2,975
| -20% | -$261K | 0.24% | 88 |
|
|
2017
Q4 | $1.24M | Sell |
14,595
-35
| -0.2% | -$2.97K | 0.28% | 81 |
|
|
2017
Q3 | $1.27M | Buy |
14,630
+1,605
| +12% | +$139K | 0.29% | 83 |
|
|
2017
Q2 | $1.01M | Buy |
13,025
+4,795
| +58% | +$370K | 0.23% | 94 |
|
|
2017
Q1 | $571K | Buy |
+8,230
| New | +$571K | 0.12% | 150 |
|